'It's Totally Irresponsible': Canadian Ethicist Slams Rogue Russian's Plan to Edit Human Embryos
By Gemma Buck,
National Post
| 07. 08. 2019
Canadian bioethicists and genetics experts are speaking out against Denis Rebrikov, the Russian molecular biologist who plans — in defiance of international scientific norms — to alter human embryos using CRISPR gene-editing technology to allow prospective parents with genetic deafness to conceive a child who can hear.
“We are putting ourselves on the path to changing the human evolutionary story. This is not up to one scientist. It’s not up to a group of scientists or a group of political elites. It’s up to all of us,” said Françoise Baylis, a professor of philosophy and bioethics at Dalhousie University who serves on a World Health Organization committee that is developing global standards and oversight for editing of the human genome.
The ethical implications of this kind of rogue science are wide-ranging and nuanced, Baylis explained. But the obvious ones are dire: Making genetic changes to eggs, sperm, or early embryos, collectively called the human germline, affects not only the eventual person these cells may become, but also their offspring.Though there is a “spectrum” of views among scientists and ethicists about...
Related Articles
Reproductive rights have been a flashpoint in national politics for decades, with the stakes surging after the Supreme Court shredded the right to an abortion. In the current presidential campaign, the battle over abortion has swelled and morphed to encompass in vitro fertilization (IVF), which has now moved rapidly from widely accepted to partisan hot button.
This dramatic shift was highlighted by the February decision of the Alabama Supreme Court that granted personhood rights to frozen IVF embryos, signaling that...
By Annalee Armstrong, BioSpace | 09.11.2024
Complex gene therapies are starting to hit the market but all have faced the same reality: a tepid reception from the healthcare system and a cloudy path to profitability.
It can take about a year for a patient to go...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...